FDA OK's Odomza from Novartis for common skin cancer type

Friday, July 24, 2015 - 14:20 in Health & Medicine

EAST RUTHERFORD, N.J. (AP) -- A new drug for advanced basal cell carcinoma, an increasingly common cancer in the skin's top layer, has won Food and Drug Administration approval....

Read the whole article on AP Health

More from AP Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net